Eosinophilic Myocarditis Presenting as Cardiac Tamponade: A Diagnostic Challenge

  • Kristine Vo Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA
  • Yoshito Nishimura Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA
  • Jennifer Yokoyama Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA
  • Amanda Wasko Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA
  • Taryn Miyake Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA
  • Kimberly Vu Queen's Heart Institute, The Queen's Medical Center, Honolulu, Hawaii, USA
  • James Zhang Queen's Heart Institute, The Queen's Medical Center, Honolulu, Hawaii, USA
  • Jesus Pino Moreno Queen's Heart Institute, The Queen's Medical Center, Honolulu, Hawaii, USA
  • Dipanjan Banerjee Queen's Heart Institute, The Queen's Medical Center, Honolulu, Hawaii, USA
  • Lisa Kim Hawaii Pathologists’ Laboratory, The Queen's Medical Center, Honolulu, Hawaii, USA
  • Christina Chong Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA

Abstract

Eosinophilic myocarditis (EM) is a rare cause of acute heart failure. It can occur secondary to drug hypersensitivity, autoimmune diseases such as vasculitis, idiopathic hypereosinophilic syndrome (HES) or malignancy, but is often under-recognized and underdiagnosed, being confused with other causes of heart failure. While EM is associated with various clinical symptoms, it is rarely associated with cardiac tamponade that requires urgent pericardiocentesis. Here we describe a patient with EM who presented with cardiac tamponade and decompensated heart failure likely secondary to autoimmune disease.

VIEW THE ENTIRE ARTICLE

References

  • Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol 2017;70(19):2363–2375.
  • Cheng CY, Baritussio A, Giordani AS, Iliceto S, Marcolongo R, Caforio ALP. Myocarditis in systemic immune-mediated diseases: prevalence, characteristics and prognosis. A systematic review. Autoimmun Rev 2022;21(4):103037.
  • Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009;124(6):1319–25.e3.
  • Furuta S, Iwamoto T, Nakajima H. Update on eosinophilic granulomatosis with polyangiitis. Allergol Int 2019;68(4):430–436.
  • Chang HC, Chou PC, Lai CY, Tsai HH. Antineutrophil cytoplasmic antibodies and organ-specific manifestations in eosinophilic granulomatosis with polyangiitis: a systematic review and meta-analysis. J Allergy Clin Immunol Pract 2021;9(1):445–52.e6.
  • Published: 2022-09-20

    Issue: 2022: LATEST ONLINE (view)

    Section: Articles

    How to cite:
    1.
    Vo K, Nishimura Y, Yokoyama J, Wasko A, Miyake T, Vu K, Zhang J, Pino Moreno J, Banerjee D, Kim L, Chong C. Eosinophilic Myocarditis Presenting as Cardiac Tamponade: A Diagnostic Challenge. EJCRIM 2022;doi:10.12890/2022_003564.

    Most read articles by the same author(s)